EF
AXSM icon

Empowered Funds’s Axsome Therapeutics AXSM Stock Holding History

Empowered Funds’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.55M Buy
20,997
+19,695
+1,513% +$3.4M 0.02% 799
2025
Q4 		$238K Buy
+1,302
New +$182K ﹤0.01% 905

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Empowered Funds's AXSM Position: Q1 2026 in Review

Empowered Funds increased its Axsome Therapeutics (AXSM) stake by 1,513% in Q1 2026, buying an estimated $3.4M and bringing the position to 20,997 shares worth $3.55M. The position accounts for 0.02% of the portfolio, ranked #799.

Empowered Funds first reported a position in AXSM in Q4 2025 and has held it in 2 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Empowered Funds held 20,997 shares of Axsome Therapeutics worth $3.55M as of Q1 2026.
  • Empowered Funds bought 19,695 Axsome Therapeutics shares in Q1 2026, an estimated $3.4M.
  • Axsome Therapeutics made up 0.02% of Empowered Funds's portfolio in Q1 2026, its #799 holding.
  • Empowered Funds first reported a position in Axsome Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.